Addition/Correction pubs.acs.org/ac
Correction to MicroRNA Conjugated Gold Nanoparticles and Cell Transfection Elizabeth Crew, Michael A. Tessel, Sharaara Rahman, Asma Razzak-Jaffar, Derrick Mott, Martha Kamundi, Gang Yu, Nuri Tchah, Jehwan Lee, Michael Bellavia, and Chuan-Jian Zhong* Anal. Chem. 2012, 84 (1), 26−29. DOI: 10.1021/ac202749p Anal. Chem. 2012, 84 (12), 5448. DOI: 10.1021/ac301532v S Supporting Information *
I
n the author list, Michael A. Tessel is added as the second author to acknowledge his role in generating the cell culture based data, and the corrected author list is as shown in this Addition and Correction manuscript. The affiliation of Michael A. Tessel is The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611, United States. The Acknowledgment Section of the original manuscript should be corrected to “This work is supported by the National Science Foundation (CHE 0848701). Dr. P.H. Gunaratne of Baylor College of Medicine is gratefully acknowledged for helpful discussion on delivery of miRNAs and the cell transfection protocol.” On page 27 of the original manuscript, in the Experimental Section, second paragraph: the sentence “Cell transfection was performed following a standard protocol.11” should be corrected as “Cell transfection was performed following the procedure as described in the Supporting Information.” On page 27 of the original manuscript, in the last paragraph: the sentence “MM.1S cells were treated with the miRNA− AuNP conjugates following a standard cell transfection procedure,11” should be corrected as “MM.1S cells were treated with the miRNA−AuNP conjugates following the procedure as described in Supporting Information.” On page 28 of the original manuscript, in the second paragraph, the sentence “Samples were treated with Cy3- or Cy5- tagged miRNA−AuNPs or by cotransfecting miR-130b mimics as a positive control.” should be corrected as “Samples were treated with Cy3- or Cy5- tagged miRNA-AuNPs or by co-transfecting miR-130b mimics with the GR 3′UTR luciferase reporter as a positive control.” Reference 13 in the original manuscript, Gunaratne, P. H.; Tessel, M. A.; Creighton, C. J.; Krett, N. L.; Rosen, S. T. Clin. Lymphoma Myeloma 2009, 9, S129, should be corrected to Gunaratne, P. H.; Tessel, M. A.; Creighton, C. J.; Krett, N. L.; Rosen, S. T. In Clin. Lymphoma Myeloma Abstract Book, Proceedings of XII International Myeloma Workshop; Washington, DC; February 26−March 1, 2009; Cheson, B. D., Jagannath, S., Eds.; CIG Media Group: Dallas, TX, 2009; B376, S129.
■
ASSOCIATED CONTENT
S Supporting Information *
Revised Supporting Information file. This material is available free of charge via the Internet at http://pubs.acs.org. Published: November 9, 2012 © 2012 American Chemical Society
10147
dx.doi.org/10.1021/ac303123z | Anal. Chem. 2012, 84, 10147−10147
